+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Presidential Gold Medal

American College of Rheumatology

Award Description: The highest award that the ACR can bestow, the Presidential Gold Medal is awarded in recognition of exemplary achievements in rheumatology over an entire career. Established by the past presidents of the ACR, candidates will have made important contributions in multiple areas such as clinical medicine, research, education, or administration.

Award Terms and Funding: A one-time, merit-based award and the recipient will receive a $5,000 cash award.

Application Requirements:
4 documents total:

1 letter of nomination from an ACR member
2 letters of support from additional ACR members
Current CV for the nominee

Application Evaluation Criteria: Applicants are evaluated on research and scholarly activities, practice or clinical excellence, education or training excellence, mentoring or coaching excellence, advocacy, and service to the ACR/ARP.

All Membership and Awards Committee recommendations are presented to the ACR Board of Directors for final approval and winners will be announced after the August board meeting.

AI Based Application Success Predictor

Based on funded projects, review criteria, and foundation priorities:

🥇 1. Strong Disease Relevance (Highest Predictor)

Must focus on:
- Rheumatoid arthritis
- Lupus
- Osteoarthritis
- Vasculitis
- Other rheumatic diseases

✔ Clear connection to patient outcomes is essential

🥈 2. Translational Research Priority

Strong preference for:
- Bench-to-bedside research
- Clinical or human-based studies

✔ High success:

Biomarker discovery
Clinical trials
Patient-centered outcomes

🥉 3. Early Career Investigator Focus

Many grants target:
- Fellows
- Junior faculty

✔ Predictor:

Strong mentor + institutional support

4. Innovation with Clinical Impact

Funded proposals often:
- Introduce novel therapeutic targets
- Improve diagnosis or disease monitoring

📌 Innovation must be clinically meaningful, not purely theoretical

5. Feasibility & Clear Methodology

Strong emphasis on:
- Realistic timelines
- Achievable milestones

✔ Especially important for:

Pilot grants
Career development awards

6. Use of Human Data / Cohorts

Preferred:
- Patient cohorts
- Clinical registries
- Human tissue samples

❌ Lower priority:

Pure animal or basic lab-only studies

7. Alignment with Foundation Priorities

Common funded areas:

Autoimmune disease mechanisms
Precision medicine
Health disparities in rheumatology
Pediatric rheumatology
Quality of care improvement

8. Strong Preliminary Data (for larger grants)

Especially important for:
- Career development awards
- Investigator grants

✔ Demonstrates feasibility and reduces risk

🧪 Patterns from Funded Projects

Biomarkers for disease activity
Targeted immunotherapy approaches
Imaging techniques (MRI, ultrasound)
Patient-reported outcomes research
AI/ML in disease prediction

⚠️ Common Reasons for Rejection

Weak link to rheumatic disease
Lack of clinical relevance
Overly basic science without translation
Poor study design or unclear endpoints
Insufficient mentorship (for early-career grants)

🧠 Bottom Line (Key Predictors Ranked)

Direct relevance to rheumatic disease
Translational / patient-focused research
Strong mentorship (early-career grants)
Innovative yet clinically meaningful idea
Feasible and well-designed study
Use of human data/cohorts

Specialties

Rheumatology

Eligibility Requirements

ACR Member in good standing

Sponsor Details

Sponsor Institute/Organizations: American College of Rheumatology

Sponsor Type: Corporate/Non-Profit

Address: 2200 Lake Boulevard NE Atlanta, Georgia 30319

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity